Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 6 51-6, 2005, Pages

  Sloniger, Julie A ^a   Saengsirisuwan, Vitoon ^a   Diehl, Cody J ^a   Dokken, Betsy B ^a   Lailerd, Narissara ^a   Lemieux, Andrew M ^a   Kim, John S ^a   Henriksen, Erik J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Glucose transport; Glycogen synthase; Hypertension; Insulin resistance

Indexed keywords

ANGIOTENSIN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; RECEPTOR SUBUNIT; RENIN; SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ESSENTIAL HYPERTENSION; HETEROZYGOSITY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE; TRANSGENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; AREA UNDER CURVE; BIOLOGICAL TRANSPORT; GLUCOSE; GLYCOGEN SYNTHASE; HYPERTENSION; INSULIN; MALE; MUSCLE, SKELETAL; ONCOGENE PROTEINS; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 19444379931     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00396.2004     Document Type: Article

References (40)

1. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10, 1997.
2. Campbell DJ, Rong P, Kladis A, Rees B, and Skinner SL. Angiotensin and bradykinin peptides in the TGR(mREN2)27 rat. Hypertension 25: 1014-1020, 1995.
3. Cooney GJ, Thompson AL, Furler SM, Ye J, and Kraegen EW. Muscle long-chain acyl CoA esters and insulin resistance. Ann NY Acad Sci 967: 196-207, 2002.
4. Cortez MY, Torgan CE, Brozinick JT, and Ivy JL. Insulin resistance of obese Zucker rats exercise trained at two different intensities. Am J Physiol Endocrinol Metab 261: E613-E619, 1991.
5. Cross DA, Alessi DR, Cohen P, Andjelkovich M, and Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789, 1995.
6. DeFronzo RA and Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
7. Denton RM and Randle PJ. Concentration of glycerides and phospholipids in rat heart and gastrocnemius muscles: effects of alloxan-diabetes and perfusion. Biochem J 104: 416-422, 1967.
8. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, and Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 317: 350-357, 1987.
9. Folch J, Lees M, and Sloane Stanley JH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957.
10. Folli F, Kahn CR, Hansen H, Bouchie JL, and Feener EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 100: 2158-2169, 1997.
11. Folli F, Saad MJ, Velloso LA, Hansen H, Feener EP, and Kahn CR. Crosstalk between insulin and angiotensin II signaling systems. Exp Clin Endocrinol Diabetes 107: 133-139, 1999.
12. Frayn KN and Maycock PF. Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. J Lipid Res 21: 139-144, 1980.
13. Ginsburg HN. Insulin resistance and cardiovascular disease. J Clin Invest 106: 453-458, 2000.
14. Hajduch E, Alessi DR, Hemmings BA, and Hundal HS. Constitutive activation of protein kinase Ba by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47: 1006-1013, 1998.
15. Hansen PA, Gulve EA, and Holloszy JO. Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J Appl Physiol 76: 979-985, 1994.
16. Henriksen EJ and Halseth AE. Early alterations in soleus GLUT-4, glucose transport, and glycogen in voluntary running rats. J Appl Physiol 76: 1862-1867, 1994.
17. Henriksen EJ, Tischler ME, and Johnson DG. Increased response to insulin of glucose metabolism in the 6-day unloaded rat soleus muscle. J Biol Chem 261: 10707-10712, 1986.
18. Holness MJ and Sugden MC. The impact of genetic hypertension on insulin secretion and glucoregulatory control in vivo: studies with the TGR(mREN2)27 transgenic rat. J Hypertens 16: 369-376, 1998.
19. Kinnick TR, Youngblood EB, O'Keefe MP, Saengsirisuwan V, Teachey MK, and Henriksen EJ. Modulation of insulin resistance and hypertension by voluntary exercise training in the TG(mREN2)27 rat. J Appl Physiol 93: 805-812, 2002.
20. Kohn AD, Summers SA, Birnbaum MJ, and Roth RA. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulated glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378, 1996.
21. Landsberg L. Insulin resistance and hypertension. Clin Exp Hypertens 21: 885-894, 1999.
22. Langheinrich M, Lee MA, Bohm M, Pinto YM, Ganten D, and Paul M. The hypertensive Ren-2 transgenic rat TGR(mREN2)27 in hypertension research: characteristics and functional aspects. Am J Hypertens 9: 506-512, 1996.
23. Lee MA, Bohm M, Kim S, Bachmann S, Bachmann J, Bader M, and Ganten D. Differential gene expression of rennin and angiotensinogen in the TGR(mREN2)27 transgenic rat. Hypertension 25: 570-580, 1995.
24. Lee MA, Bohm M, Paul M, Bader M, Ganten U, and Ganten D. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol Endocrinol Metab 270: E919-E929, 1996.
25. Mullins JJ, Peters J, and Ganten D. Fulminant hypertension in transgenic rats harboring the Ren-2 gene. Nature 344: 541-544, 1990.
26. Ogihara T, Asano T, Katsuyuki A, Chiba Y, Sakoda H, Anai M, Shojima N, Ono J, Onishi Y, Fujishiro M, Katagiri H, Fukushima Y, Kikuchi M, Noguchi N, Aburatani H, Komuro I, and Fujita T. Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 40: 872-879, 2002.
27. Pirola L, Bonnafous S, Johnston AM, Chaussade C, Portis F, and Van Obberghen E. Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells. J Biol Chem 278: 15641-15651, 2003.
28. Reaven GM. Are insulin resistance and/or compensatory hyperinsulinemia involved in the etiology and clinical course of patients with hypertension? Int J Obes 19: S2-S5, 1995.
29. Richey JM, Ader M, Moore D, and Bergman RN. Angiotensin II induces insulin resistance independent of changes in interstitial insulin. Am J Physiol Endocrinol Metab 277: E920-E926, 1999.
30. Rodriguez-Pena A and Rozengurt E. Phosphorylation of an acidic mol. wt 80 000 cellular protein in a cell-free system and intact Swiss 3T3 cells: a specific marker of protein kinase C activity. EMBO J 5: 77-83, 1986.
31. Sander M, Bader M, Djavidani B, Maser-Gluth C, Vecsei P, and Mullins J. The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27. Endocrinology 131: 807-814, 1992.
32. Schmitz-Peiffer C. Protein kinase C and lipid-induced insulin resistance in skeletal muscle. Ann NY Acad Sci 967: 146-157, 2002.
33. Srere PA. Citrate synthase. Methods Enzymol 13: 3-10, 1969.
34. Summers SA, Kao AW, Kohn AD, Backus GS, Roth RA, Pessin JE, and Birnbaum MJ. The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism. J Biol Chem 274: 17934-17940, 1999.
35. Thomas JA, Schlender KK, and Larner J. A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem 25: 486-499, 1968.
36. Ueki K, Yamamoto-Honda R, Kaburagi Y, Yamauchi T, Tobe K, Burgering BMT, Coffer PJ, Komuro I, Akanuma Y, Yazaki Y, and Kadowaki T. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 273: 5315-5322, 1998.
37. Uyeda K and Racker E. Regulatory mechanisms in carbohydrate metabolism. VII. Hexokinase and phosphofructokinase. J Biol Chem 240: 4682-4688, 1965.
38. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, and Kahn CR. Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 93: 12490-12495, 1996.
39. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, and Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002.
40. Zierath JR, Krook A, and Wallberg-Henriksson H. Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43: 821-835, 2000.